The registration reinforces PhotonPay’s regulatory foundation for payment activities in Canada, with requirements covering operational risk management, incident response and the safeguarding of end-user funds.
HONG KONG SAR – Media OutReach Newswire – 10 November 2025 – PhotonPay today announced that its Canadian operating entity, Photon Dance CA Inc., is now registered with the Bank of Canada as a payment service provider (PSP) under Canada’s Retail Payment Activities Act (RPAA). The entity was previously registered with the Financial Transactions and Reports Analysis Centre of Canada (FINTRAC) as a Money Services Business (MSB). The RPAA registration further strengthens PhotonPay’s regulatory foundation in Canada and supports its continued development of local financial services across North America.
The RPAA establishes a federal framework for the registration and supervision of PSPs conducting specified retail payment activities in Canada. Administered by the Bank of Canada, it sets requirements for operational risk management, incident response and regulatory reporting. PSPs that hold end-user funds are also required to implement measures to safeguard those funds, strengthening oversight and accountability across Canada’s retail payments ecosystem.
The Canadian registration adds to PhotonPay’s broader regulatory presence across North America. In the United States, PhotonPay is registered as a Money Services Business with the Financial Crimes Enforcement Network (FinCEN) and holds money transmitter licenses across multiple U.S. states. Across the Americas, Europe and Asia, PhotonPay holds 35 payment licenses, regulatory authorizations and registrations, reflecting the regulatory breadth behind its operations across key financial markets.
For PhotonPay, building a global financial operating system requires more than connecting payment capabilities across markets. It also means developing the local regulatory and financial infrastructure needed to support those capabilities in each jurisdiction. As businesses expand internationally, their financial operations increasingly span different account structures, payment systems, currencies and regulatory environments. Bringing these functions together requires infrastructure that can address local market requirements while giving businesses a more unified way to manage their global finances.
This is the vision behind PhotonPay’s next-generation Financial OS. Through an integrated, API-first architecture, PhotonPay brings together multi-asset wallets, local collections, global payouts, foreign exchange, card issuing and embedded finance. By supporting both fiat currencies and stablecoins within its broader financial infrastructure, the platform connects traditional payment rails with emerging digital-asset capabilities, helping businesses manage increasingly complex financial operations across markets.
“Global financial infrastructure must be designed around the realities of the markets it serves. Regulatory frameworks, payment systems and the responsibilities involved in handling funds differ across jurisdictions, and these differences need to be accounted for at the infrastructure level,” said JP Pi, Global Chief Compliance Officer at PhotonPay. “Our approach is to build a Financial OS that brings together global capabilities while respecting the regulatory and operational requirements of each local market. The RPAA registration is another step in putting that approach into practice, as we continue developing infrastructure to support businesses operating across an increasingly interconnected financial landscape.”
The issuer is solely responsible for the content of this announcement.
About PhotonPay
Founded in Hong Kong in 2015, PhotonPay is a global fintech company building a next-generation, stablecoin-centric Financial Operating System (Financial OS). Its API-first architecture brings together multi-asset wallets supporting stablecoins and fiat currencies, global money movement, foreign exchange, global card issuing, embedded finance, and local clearing infrastructure, connecting digital and traditional financial rails within an integrated financial system.
PhotonPay operates 16 offices worldwide, employs nearly 600 people, and holds 35 payment and financial licenses and regulatory authorizations across the Americas, Europe and Asia. The company serves businesses across more than 200 countries and territories.
Huawei has officially launched Signals of Change, a four-part documentary series that, for the first time, offers global audiences a comprehensive look at the company’s major technological innovations in wireless communications over more than three decades.
The documentary highlights Huawei’s landmark innovations, including Distributed Base Stations, SingleRAN, Massive MIMO, Polar Code, MetaAAU, and “0 Bit 0 Watt”.
Through real-world scenarios such as high-speed rail connectivity, network coverage in extreme environments, and connectivity at major sporting events, the documentary hears from global telecom operators, industry analysts, and other stakeholders to showcase the global impact and value of Huawei’s wireless innovations.
SHENZHEN, CHINA – Media OutReach Newswire – 6 November 2026 – Huawei today officially launched Signals of Change, a new documentary series that, for the first time, charts the company’s major technological innovations in wireless communications over more than three decades. Produced by Huawei in collaboration with CNN International’s brand studio Create, the series will be broadcast worldwide.
Huawei’s wireless business began in 1994, but it was in the early 2000s that it began to break into international markets. Huawei developed its distributed base station innovation, marking a historic breakthrough into the European wireless communications market. From its early struggles to gain a foothold to its determined progress in recent years, Huawei has consistently sought to overcome obstacles through innovation and meet challenges with resilience, continuing to advance amid technological transformation and intense market competition.
Through real-world scenarios such as high-speed rail connectivity, network coverage in extreme environments, and connectivity at major sporting events, the documentary hears from representatives of leading global telecom operators, industry analysts, Huawei executives, and R&D experts. It revisits landmark innovations including Distributed Base Stations, SingleRAN, Massive MIMO, and “0 Bit 0 Watt”, tracing Huawei’s journey from an industry newcomer to a leader in technological innovation and industry development.
Episode 1: Small Station, Giant Leap: How the World Was Connected
From Distributed Base Stations to SingleRAN: Driving Mobile Network Deployment Through Architectural Innovation
On a high-speed train traveling at nearly 350 kilometers per hour, a surgeon can download hundreds of CT scan images over a mobile network to provide timely remote medical consultations. At altitudes exceeding 6,000 meters in the Mount Everest region, scientific researchers can stay connected with colleagues thousands of miles away through real-time video links, enabling remote scientific collaboration. From high-speed railways to the roof of the world, the first two episodes of the documentary explore how mobile communications technology continues to overcome the limitations of speed and geography. To trace the architectural innovations behind these advances, the story takes us back more than two decades to the early days of 3G network deployment in Europe.
In the early 2000s, European telecom operators faced significant challenges in deploying 3G networks, including difficulties in acquiring sites, lengthy deployment cycles, and high costs. In 2004, Huawei engineers visited customer sites to gain firsthand insights into these challenges and pioneered a distributed base station architecture comprising a compact Baseband Unit (BBU) and Remote Radio Units (RRUs). This innovation enabled operators to deploy network equipment more flexibly while significantly reducing network construction costs. Huawei’s distributed base stations were first deployed in the Netherlands in 2005, followed by large-scale commercial deployment in Spain in 2006. Over time, the distributed base station became a mainstream architecture for mobile network deployment worldwide.
As the coexistence of 2G, 3G, and other mobile networks created growing challenges of duplicated infrastructure, Huawei made further breakthroughs in key technologies, including GSM multi-carrier digital predistortion (DPD), and introduced its SingleRAN solution. By integrating multiple radio access technologies on a unified hardware platform, SingleRAN enabled operators to deploy different network standards together and smoothly evolve their networks across successive generations of mobile technology. In 2008, a German telecom operator became the first in Germany to deploy Huawei’s multi-mode base station solution, marking the beginning of SingleRAN’s commercial adoption in Europe. Since then, SingleRAN has been widely deployed around the world, driving the evolution of mobile networks toward multi-band, multi-mode integration while helping operators significantly reduce network deployment and operating costs.
From Massive MIMO to Polar Code Implementation: Turning Cutting-Edge Research into Real-World Applications
At the Nanjing Olympic Sports Center, 62,356 football fans gathered for the Su Super League final. Spectators shared highlights in real time on their smartphones, with photos, videos, and live-streaming data flowing rapidly across mobile networks. This high-density connectivity, featured in Episode 3, reflects the explosive growth in data demand in the mobile internet era. How to accommodate ever-increasing data traffic using limited spectrum resources has long been a major technical challenge for the mobile communications industry.
Huawei has continuously invested in Massive MIMO (Multiple-Input Multiple-Output) research, leveraging innovations such as large-scale antenna arrays to bring this cutting-edge technology from theoretical research to commercial deployment. In 2015, Huawei worked with an operator partner in Shanghai to successfully validate Massive MIMO in a commercial network environment. Today, Massive MIMO has become one of the key technologies underpinning 5G networks, laying a solid technological foundation for the world’s transition to the 5G era.
Meanwhile, Huawei has continued to explore innovations in fundamental research. In 2008, Turkish scientist Erdal Arıkan introduced the theory of Polar Codes, opening up a new direction in channel coding technology. Building on this theoretical breakthrough, Huawei invested in Polar Code encoding and decoding algorithms and system-level validation. In 2016, through the efforts of Huawei and global industry partners, Polar Codes were selected by 3GPP as the coding scheme for 5G enhanced Mobile Broadband (eMBB) control channels, becoming an important part of the international 5G standard.
From MetaAAU to “0 Bit 0 Watt”: Delivering Superior Network Performance with Ultra-Low Energy Consumption
Episode 4 shifts the focus to the green transformation of wireless networks. As demand for mobile connectivity continues to grow, reducing network energy consumption while meeting rising performance requirements has become a shared challenge for telecom operators worldwide.
In 2021, Huawei launched MetaAAU, its next-generation Massive MIMO product. Through innovations including ultra-large-scale antenna arrays, MetaAAU pushed beyond the performance limitations of conventional antenna architectures. By enhancing network coverage while reducing energy consumption by approximately 30%, MetaAAU has helped operators achieve both higher network performance and greater energy efficiency.
In 2021, Huawei and its European customers jointly introduced the “0 Bit 0 Watt” concept. Through coordinated innovations in hardware, materials, software, and intelligent network management, the solution enables wireless equipment to enter ultra-deep sleep modes during periods of low traffic and wake up on demand, reducing network energy consumption while maintaining user experience. In 2024, the solution received the GSMA GLOMO Award for “Best Mobile Technology Breakthrough”, offering a new technological pathway for telecom operators worldwide to advance their green transformation.
A Journey of Relentless Innovation: Driven by Customer Needs and Scientific Advancement
From transforming base station architectures to enabling multi-standard network integration, from breakthroughs in key algorithms to contributing to global standards, and from continuous product evolution to achieving ultra-low energy consumption, Huawei’s journey of wireless innovation over more than three decades has been guided by a consistent commitment: addressing customer needs to drive innovation and scientific exploration to push technological boundaries. These efforts have continuously advanced global network capabilities, creating new possibilities for the digital economy and a more connected society.
Looking ahead, Huawei will remain committed to its dual-driver approach to innovation, continue to increase investment in fundamental research and development, respect and protect intellectual property rights, and embrace openness and mutually beneficial collaboration. Working alongside partners worldwide, Huawei aims to advance mobile communications technology and contribute to a thriving global industry ecosystem.
Where to Watch:
Watch the documentary via media’s YouTube link, or follow Huawei’s official social media channels to discover the full story of the Signals of Change documentary series.
Q1: Why has Huawei chosen to release this documentary series on wireless innovation now?
A: Huawei aims to offer global audiences a comprehensive look at its major technological innovations over more than three decades. Through authentic stories, technological breakthroughs, and industry achievements, the documentary showcases Huawei’s capabilities in original innovation and raises awareness of its contributions.
The global mobile communications industry is entering a pivotal stage in the development of next-generation networks. Through this documentary, Huawei hopes to highlight its long-standing commitment to innovation driven by both customer needs and scientific advancement, sustained investment in fundamental research, and collaborative innovation with global partners. Huawei will continue to carry these principles forward as it explores new technologies and contributes to the development of next-generation mobile networks.
Q2: How do the technological innovations featured in the documentary relate to people’s everyday lives?
A: The mobile connectivity we take for granted today is built on decades of continuous technological innovation. From distributed base stations that made mobile network deployment more flexible and cost-effective, to SingleRAN, which enabled the integration and smooth evolution of different generations of mobile networks, and Massive MIMO, which dramatically increased network capacity, each breakthrough has expanded the possibilities of mobile communications. More recently, innovations such as MetaAAU and “0 Bit 0 Watt” have helped operators achieve both improved network performance and greater energy efficiency.
Whether staying connected on a high-speed train, sharing memorable moments in a stadium filled with tens of thousands of fans, or accessing reliable mobile services in remote areas, these everyday experiences depend on the combined capabilities of multiple generations of communications technology. The documentary aims to show audiences that the seamless connectivity we expect is the result of generations of technological progress—and that these innovations will continue to shape our digital lives in the years ahead.
Hashtag: #Huawei
The issuer is solely responsible for the content of this announcement.
Premiums as low as HK$1 per day, simple underwriting and broad cancer drug treatment coverage help customers protect their health and get covered with ease
HONG KONG SAR – Media OutReach Newswire – 9 November 2026 – AIA Hong Kong & Macau announced the launch of FutureShield Cancer Drug Plan (“FutureShield”), a new medical protection insurance plan designed to help customers manage the rising cost of cancer drug treatments and access evolving treatment options with greater confidence. The plan reimburses eligible expenses for covered cancer drugs1 and supportive medications2 prescribed for medically necessary active treatment3 or palliative treatment4 of the insured’s covered cancer5, as long as such medications are prescribed to and received by the insured in a public hospital in Hong Kong or Macau, or in a hospital in the Chinese Mainland.
AIA Hong Kong & Macau announced the launch of FutureShield Cancer Drug Plan, a new medical protection insurance plan designed to help customers manage the rising cost of cancer drug treatments and access evolving treatment options with greater confidence.
Cost-Effective, Simplified Underwriting and Broad Cancer Drug Treatment Options
In Hong Kong’s public hospitals, certain drugs are self-financed. While assistance programmes are available to eligible patients, they are means-tested and may still involve significant out-of-pocket costs for some families. Statistics show that 50,000 public-hospital patients in Hong Kong required self-financed drugs each year, and amongst them, annual costs can approach HK$1 million.6 In some cases, cancer drugs can account for nearly 80% of total cancer treatment costs.7
In response to the rising cost of cancer drug treatment, FutureShield offers a cost-effective premium option from as low as HK$1 per day8, together with a Covered Cancer Limit of up to HK$5 million9, helping customers better manage the financial burden of cancer drug treatment when needed.
To help customers access cancer drug protection more easily, the plan features simplified underwriting based on health-related questions, with no medical examination required. Even individuals with common chronic conditions, such as high blood pressure, high blood sugar or high cholesterol, may still be eligible for coverage. The plan reimburses covered cancer drugs¹ and supportive medications² prescribed to and received by the insured in a public hospital in Hong Kong or Macau, or in a hospital in the Chinese Mainland, including drugs approved in the future10. This allows customers to stay protected as cancer medicine advances, supporting both current and future treatment needs.
Ms Alice Liang, Chief Proposition & Healthcare Officer of AIA Hong Kong & Macau, said: “Cancer remains one of the most pressing health concerns facing Hong Kong families today. While advances in cancer treatment are creating new possibilities and improving outcomes, the high cost of newer cancer therapies and the longer treatment duration of certain cancers can also create considerable financial pressure for patients and their families.
“FutureShield Cancer Drug Plan reflects AIA’s Integrated Healthcare Strategy and our commitment to creating positive social impact. By combining affordable cancer drug protection, simplified underwriting, broad coverage for cancer treatment options and cross-boundary cancer drug support11, we aim to make quality cancer medical treatment more accessible, affordable and effective. Through this customer-centric innovation, we are helping more cancer patients access treatment with greater confidence while supporting our promise to help people live Healthier, Longer, Better Lives.”
Supporting Cancer Treatment Across Hong Kong, Macau and the Chinese Mainland
Covered areas of FutureShield include public hospitals in Hong Kong and Macau, as well as hospitals in the Chinese Mainland. In addition, with growing interest in accessing cancer treatment options across Hong Kong and the Mainland Greater Bay Area (GBA)12, customers may face challenges in identifying suitable medical providers and navigating cross-boundary treatment arrangements. Cross-boundary Cancer Drug Support11, a value-added service, helps customers identify designated medical providers and registered medical practitioners in Hong Kong and the Mainland GBA12,13 that can provide their prescribed cancer drugs and assists with appointment coordination, providing greater convenience throughout the treatment journey.
Key Features of FutureShield Cancer Drug Plan:
Cancer Drug Reimbursement Benefit and Supportive Medication Reimbursement Benefit providing reimbursement for eligible expenses of covered cancer drugs1 and supportive medications2 prescribed for medically necessary active treatment3 or palliative treatment4 of the insured’s covered cancer5.
Future-ready coverage designed to evolve alongside advances in cancer medicine by covering covered cancer drugs1 and supportive medications2approved by recognised drug regulatory authorities.10
Multiple covered areas covering treatment received in public hospitals in Hong Kong and Macau, as well as hospitals in the Chinese Mainland.
Cross-boundary Cancer Drug Support11 (value-added service) that helps customers navigate treatment pathways and coordinate access to prescribed cancer drugs across Hong Kong and the Mainland GBA12.
Resettable Covered Cancer Limits5, 14 of up to HK$1 million, replenished every three consecutive years until the total amounts paid under Cancer Drug Reimbursement Benefit and Supportive Medication have reached the Lifetime Cancer Limit10 of HK$5 million, to support customers throughout longer-term treatment journeys.
Additional Caring Benefits that provide support beyond cancer drug treatment, including transportation fee subsidy, medical appliances, and wig and voice box expenses.
Frequently Asked Questions
What is FutureShield Cancer Drug Plan?
FutureShield Cancer Drug Plan is a medical protection insurance plan designed to help customers manage the rising cost of cancer drug treatments and access evolving treatment options with greater confidence. The plan reimburses eligible expenses for covered cancer drugs1 and supportive medications2 prescribed for medically necessary active treatment3 or palliative treatment4 of the insured’s covered cancer5, as long as such medications are prescribed to and received by the insured in a public hospital in Hong Kong or Macau, or in a hospital in the Chinese Mainland, including drugs approved in the future10. This allows customers to stay protected as cancer medicine advances, supporting both current and future treatment needs.
How does FutureShield Cancer Drug Plan make cancer drug protection more accessible?
To help customers access cancer drug protection more easily, FutureShield features simplified underwriting based on health-related questions, with no medical examination required. Even individuals with common chronic conditions, such as high blood pressure, high blood sugar or high cholesterol, may still be eligible for coverage. The plan also offers a cost-effective premium option from as low as HK$1 per day8, together with a Covered Cancer Limit of up to HK$5 million9, helping customers better manage the financial burden of cancer drug treatment when needed.
How does the Cross-boundary Cancer Drug Support value-added service help customers identify suitable medical providers and navigate cross-boundary treatment arrangements?
FutureShield Cancer Drug Plan includes the Cross-boundary Cancer Drug Support11, a value-added service that helps customers identify designated medical institutions and registered medical practitioners12,13 in Hong Kong or the Mainland Greater Bay Area that can provide their prescribed cancer drugs and assists with appointment coordination, providing greater convenience throughout the treatment journey.
Remarks:
1
The term “Covered Cancer Drug(s)” means any pharmaceutical or biological medicinal product that is labelled as anti-cancer drug, and which has been approved by a recognised drug regulatory authority of such place where the cancer drug is prescribed to and received by the insured that the cancer drug is for the purposes of Active Treatment or Palliative Treatment and for targeting a Covered Cancer and any related complications (if applicable). Covered Cancer Drug shall specifically exclude any pharmaceutical or biological product used in surgery, radiotherapy, proton therapy or cell therapy. For details of the definition of “Covered Cancer Drug(s)”, please refer to the policy contract.
2
The term “Supportive Medication” means any pharmaceutical or biological medicinal product, other than the Covered Cancer Drug, which (a) is prescribed to the insured due to the medically necessary Active Treatment or Palliative Treatment of the insured’s Covered Cancer, and (b) has been approved for such use by a recognised drug regulatory authority of such place where the Supportive Medication is prescribed to and received by the insured. Supportive Medication includes anti-nausea drugs, anti-rejection drugs, anti-vertigo drugs, anti-anodyne, and long-term medications which are required by the insured following the Active Treatment or Palliative Treatment of the insured’s Covered Cancer such as hormone replacement therapy. For details of the definition of “Supportive Medication”, please refer to the policy contract.
3
The term “Active Treatment” means any therapeutic intervention with the aim of prolonging the insured’s life, for example, radiotherapy, chemotherapy, targeted therapy, hormonal therapy, immunotherapy, proton therapy and surgery approved for targeting a Covered Cancer and any related complications (if applicable). It does not include any treatment given solely as Palliative Treatment.
4
The term “Palliative Treatment” means treatment intended only to improve the quality of the insured’s life in the case of a life threatening covered cancer by relieving pain or alleviating other symptoms of the covered cancer and any related complications (if applicable), or the side effects of its/their treatment, without any attempt at its/their cure.
5
The term “Covered Cancer(s)” refers to “Cancer” which (a) have been occurring for more than 1 year after the issue date or the latest commencement date of the policy, whichever is later, and (b) have been investigated, diagnosed, or treated or when its signs or symptoms have manifested. For details of the definition of “Covered Cancer”, please refer to the policy contract. The term “Cancer” means all stages of malignant cancer and carcinoma-in-situ, but will specifically exclude the following: (a) any tumour which is histologically classified as pre-malignant; (b) abnormal lesions of cervix uteri classified as cervical intra-epithelial neoplasia grade I (CIN I) and grade II (CIN II); and (c) any cancer where HIV infection is also present. The cancer must be confirmed by the insured’s attending registered medical practitioner in writing and supported by clinical, radiological, histological or laboratory evidence reasonably acceptable to us. Please refer to the policy contract for details and the claim conditions.
6
《公營醫療收費改革 改革公營資助 加強醫療保障》(Unofficial English translation: Public healthcare fees and charges reform, Reforming public healthcare subsidies to enhance medical protection), Hong Kong Health Bureau, 2025
7
《香港癌症治療費用2026丨公私營醫院治癌費用外還有什麼要注意?》(Unofficial English translation: Hong Kong cancer treatment costs 2026: Key considerations beyond public and private hospital expenses), am730, 2026
8
Assuming a 30-year-old non-smoking male, the standard annual premium paid for the first year at the time of application is HK$369 (approximately HK$1 per day). Premium payable is based on the insured’s attained age and the applicable annual premium schedule at the time of application or renewal of the cover.
9
The Lifetime Cancer Limit is the maximum aggregate amount paid and/or payable during the lifetime of the insured under the Cancer Drug Reimbursement Benefit and the Supportive Medication Reimbursement Benefit in respect of eligible expenses incurred in public hospitals in Hong Kong and Macau, and in hospitals in Chinese Mainland.
10
FutureShield Cancer Drug Plan only covers Covered Cancer Drugs and Supportive Medications which have been approved for such use by a recognised drug regulatory authority of the place where the medications are prescribed to and received by the insured.
11
The Cross-boundary Cancer Drug Support is a value-added service and does not form part of the contractual terms and benefits of any insurance policy, and is non-guaranteed. The Service is provided by the designated third-party service provider, subject to the terms and conditions applicable to the Service. The Service is provided in Hong Kong and the designated cities within the Mainland GBA and not applicable in Macau. AIA reserves the right to amend, suspend or terminate the Service, any part thereof, service provider(s), or to change any terms and conditions relating thereto at any time without prior notice at its absolute discretion. For details of the Service and applicable limitations, please refer to the service leaflet or contact AIA for enquiry.
12
“Greater Bay Area (GBA)” refers to the Guangdong-Hong Kong-Macau Greater Bay Area. “Mainland GBA” refers to the Guangdong-Hong Kong-Macau Greater Bay Area, excluding Hong Kong and Macau.
13
The designated medical providers and registered medical practitioners referred to above are those within the Service Provider’s medical network in Hong Kong and the Mainland GBA that are available under the Cross-boundary Cancer Drug Support. For details, please refer to the service leaflet or contact the Service Provider’s customer service hotline at (852) 2607 9655.
14
Covered Cancer Limit and Covered Cancer Sub-limits are applicable to all Covered Cancers suffered by the insured and such limits will be replenished every 3 consecutive years, commencing from the date of first diagnosis of the first Covered Cancer suffered by the insured. Covered Cancer Limit and Covered Cancer Sub-limits shall become zero and the policy will terminate when the total amounts paid under Cancer Drug Reimbursement Benefit and Supportive Medication Reimbursement Benefit during the lifetime of the insured reaches the Lifetime Cancer Limit. Any unused limits of the Covered Cancer Limit and the Covered Cancer Sub-limits cannot be carried forward to the next 3-year period, and the total amount(s) paid out under the Cancer Drug Reimbursement Benefit and the Supportive Medication Reimbursement Benefit within each 3-year period cannot exceed the Lifetime Cancer Limit. The above is subject to policy terms and limits.
Important Information:
All information above is for reference only and does not constitute any offer and/or insurance product recommendation. The product information in this material does not contain the full terms of the policy. The precise terms and conditions of FutureShield are specified in the policy contract. For the details of the product features, terms and conditions, exclusions, product limitation and key product risks, please refer to the product brochure and policy contract of relevant products or visit the AIA Hong Kong’s website. In case you want to read policy contract sample before making an application, you can obtain a copy from AIA. Life insurance policies are long-term contracts of insurance. Should you surrender the policy early, you may receive an amount considerably less than the total amount of premiums paid. You may choose to purchase the above Plan(s) as a standalone plan without purchasing other type(s) of insurance products at the same time. You have the right to purchase FutureShield Cancer Drug Plan as a standalone plan without purchasing other insurance products at the same time.
The issuer is solely responsible for the content of this announcement.
About AIA Hong Kong & Macau
AIA Group Limited established its operations in Hong Kong in 1931. To date, AIA Hong Kong and AIA Macau have more than 19,000 financial planners*, as well as an extensive network of independent financial advisors, brokerage and bancassurance partners. We serve over 3.8 million customers^, offering them a wide selection of professional services and products ranging from individual life, group life, accident, medical and health, pension, personal lines insurance to investment-linked assurance schemes with numerous investment options. We are also dedicated to providing superb product solutions to meet the financial needs of high-net-worth customers.
* As at 30 September 2026 ^ Including AIA Hong Kong and AIA Macau’s individual life, group insurance and pension customers (as at 30 September 2026)
TONGXIANG, CHINA – Media OutReach Newswire – 9 November 2025 – From August to September 2026, South Korean actress Kim Hee-sun and Korean influencers visited Wuzhen, Zhejiang Province, experiencing traditional crafts, boat rides and water town life. Their social media posts drew attention to the “Wuzhen route,” introducing the 1,300-year-old town to travelers from South Korea and Southeast Asia.
The trend began with Kim Hee-sun’s visit, followed by Korean creators exploring boat rides, heritage workshops, Xizha’s night scenery and waterfront breakfasts. Their experiences offered international audiences a glimpse into traditional Chinese culture and Wuzhen’s charm.
Why Wuzhen? Located in Jiaxing, Zhejiang Province, it is among China’s first designated Historic and Cultural Towns, a national 5A tourist attraction and the permanent host of the World Internet Conference Wuzhen Summit. Its canals, stone bridges and traditional houses embody Jiangnan’s water town scenery. Dongzha preserves local customs, while Xizha offers nighttime sightseeing, waterfront accommodation and resort facilities. The Wuzhen Theatre Festival and Mu Xin Art Museum connect heritage with contemporary culture. Connections to Shanghai and Hangzhou make Wuzhen accessible to international visitors.
For Korean creators, Wuzhen offers more than scenery. Visitors can explore traditional craftsmanship at blue calico dyeing workshops and Yida Silk Workshop, sample local pastries such as gusao bing and dingsheng gao, and watch Dongzha’s boat-based martial arts and high-pole performances. These experiences bring local traditions to life.
Traditional sculling boats capture Wuzhen’s unhurried rhythm, gliding past whitewashed houses, stone bridges and waterfront homes. Mornings bring tea gatherings and floating markets; afternoons invite visits to Lingshui Residence and Zhaoming Academy. At dusk, Xizha’s illuminated canals create a peaceful setting before an overnight stay at a waterfront guesthouse.
Growing Korean interest also reflects changing travel preferences. With easier travel between China and South Korea, visitors increasingly seek cultural immersion, relaxation and longer stays. Wuzhen has improved international card payments, currency exchange and multilingual services. Travelers are moving beyond sightseeing toward experiencing everyday local life, supported by the town’s heritage and hospitality facilities.
From celebrity visits to social media sharing, the “Wuzhen route” offers East Asian urban travelers a chance to slow down. Whether enjoying a boat ride, traditional craft or waterfront overnight stay, visitors from Korea and beyond are invited to discover China’s water town lifestyle. Come to Wuzhen and spend a day at your own pace.
Hashtag: #Wuzhen
The issuer is solely responsible for the content of this announcement.
Real-World Experience Meets the Demands of Crisis Response In anesthesia practice, a crisis can develop within moments. An airway emergency, severe bleeding, or sudden cardiovascular instability demands more than individual knowledge: teams must assess the situation, communicate clearly, coordinate roles, and act decisively while keeping patient safety at the centre.
Against this clinical backdrop, nine finalist teams representing major teaching hospitals, referral centres, and regional anesthesia services across Indonesia brought experience from diverse perioperative and critical-care settings to the stage. From case presentation to live simulation and debriefing, the teams demonstrated how they would identify priorities, interpret evolving clinical information, and coordinate their response when a crisis disrupts routine practice. The finalists were:
ARISE-UI — RS Cipto Mangunkusumo
ThinkTank Team— RSUP Dr. M. Djamil Padang
Balinesthesia 1— RSUP Prof Dr. IGNG Ngoerah Denpasar 1
Code Blue Studio— RS Prof dr Chairuddin Panusunan Lubis
Anestesi Unpad— RSUP Dr. Hasan Sadikin Bandung
GAMA-CITO— RSUP Dr. Sardjito
Aremanest UB — RSUD Saiful Anwar Malang
Balinesthesia 2— RSUP Prof Dr. IGNG Ngoerah Denpasar 2
IAC Anestesi Unsoed— RSUD Margono Soekarjo
From Expert Assessment to Shared Professional Learning The live final was guided by a distinguished panel of anesthesia and intensive care experts from Indonesia and the Philippines. Their combined clinical, educational, and professional experience brought depth to the evaluation, which considered broad dimensions including case design, clinical management, technical and non-technical performance, patient safety, and the educational value of debriefing.
Following the final assessment, IAC Anestesi Unsoed from RSUD Margono Soekarjo emerged as the national champion and will advance to the planned 2027 Asia Grand Final in Malaysia. The value of the final extended beyond the ranking. Through observation, expert feedback, and professional discussion, the live format enabled participants and observers to compare approaches to the same underlying pressures, examine the role of leadership and teamwork, and exchange practical perspectives on crisis response. This is the central purpose of simulation-based competition: to turn demanding scenarios into a shared learning experience that can inform future practice.
Building the Next Stage of Collaboration During the event, Comen Medical and PERDATIN signed a Memorandum of Understanding on strategic cooperation in medical education, simulation-based training, and academic exchange. The MOU provides a framework for the two parties to explore future collaboration in areas such as simulation-based learning programmes, hands-on workshops, continuing education activities, and professional exchange, with specific initiatives to be developed through separate agreements and work plans.
More than a competition, CO-Anesthesia connects real clinical experience with structured simulation and cross-border exchange. Following the Indonesia final, competitions in India, and the Philippines will continue the series, extending its focus on team readiness and professional learning across more anesthesia communities.
The issuer is solely responsible for the content of this announcement.
About Comen Medical
Comen Medical, founded in 2002, is a research-driven enterprise committed to independent innovation. For over two decades, the company has been dedicated to the fields of life support, medical imaging, and informatization, while continuously expanding into in-vitro diagnostics (IVD) and large-scale surgery. For more information, please visit https://en.comen.com/.
BANGKOK, THAILAND – Media OutReach Newswire – 9 November 2026 – The Ministry of Higher Education, Science, Research and Innovation (MHESI), through the National Innovation Agency (Public Organization) (NIA), hosted the annual National Innovation Day 2026 awards ceremony. The event honors and commemorates the extraordinary innovation visionary, His Majesty King Bhumibol Adulyadej The Great (Rama IX)—revered as the “Father of Thai Innovation”—whose royal initiative, the Klaeng Din (soil aggravation) project, demonstrated pioneering resource management. During the ceremony, the NIA announced the winners of the prestigious National Innovation Awards, celebrating outstanding Thai innovators and forward-thinking organizations across the public, private, and academic sectors whose contributions generate tangible value for institutions, society, and the nation. Concurrently, the ceremony featured the presentation of the Innovation Thailand Awards and the Thai Rice Innovation Awards, both longstanding collaborative initiatives spearheaded by the NIA.
Dr. Krithpaka Boonfueng, Executive Director of the National Innovation Agency (NIA), said that National Innovation Day remains an essential annual forum dedicated to commemorating the royal grace, genius, and enduring innovation legacy of King Bhumibol Adulyadej The Great. The Ministry of Higher Education, Science, Research and Innovation strongly believes that human capital is the cornerstone of building an innovation-driven society. Consequently, the NIA prioritizes workforce upskilling across all generations alongside deploying technology and innovation to mitigate inequality, expand economic opportunities, enhance quality of life, and sharpen national competitiveness. This mission accelerates Thailand’s transition from a mere consumer of technology into a prolific creator of high-value innovation. The event serves not only as a platform to recognize trailblazers, but also as a catalyst to foster widespread awareness, stimulate active technology adoption, showcase Thai ingenuity on the world stage, and collectively advance Thailand toward becoming a sustainable “Innovation Nation.”
“The National Innovation Awards represent the highest distinction in Thailand’s innovation landscape. They celebrate Thai innovators whose pioneering work delivers clear, measurable value to the country, sparking pride and creative momentum across all sectors while elevating our national image as an emerging Innovation Nation,” stated Dr. Krithpaka. “Now in its 22nd year, the competition reflects a rapid leap forward in domestic innovation capability, keeping pace with an evolving global landscape. Historically, more than 6,736 submissions have entered the awards, with over 370 projects recognized, collectively generating an economic, social, and environmental impact valued at over 138 billion baht.”
Dr. Krithpaka highlighted three winning innovations from the 2026 National Innovation Awards that exemplify success across economic, social, and environmental dimensions, underscoring Thai entrepreneurs’ capacity to combine deep technology with commercial viability:
1. BUZZEBEES: Elevating CRM through AI to Boost Marketing Efficiency and Business Growth Developed by Buzzebees Co., Ltd., this end-to-end customer relationship management (CRM) and online engagement platform secured first prize in the Economic category (Large and Medium Enterprise division). Powered by advanced AI algorithms, the platform streamlines customer data management, consumer behavior analytics, and precision-targeted marketing campaigns. It empowers enterprises to connect with target demographics accurately, retain customer bases, and unlock new revenue streams.
The comprehensive suite encompasses loyalty and points-redemption programs, payment and order management workflows tailored for SMEs and restaurants, and e-commerce channel operations, alongside targeted digital media and affiliate marketing powered by a vast influencer and Key Opinion Leader (KOL) network. By leveraging real-time business diagnostics and automated campaign personalization, the platform can deploy fully functional solutions within just five business days—a 20-fold reduction in turnaround time compared to traditional development cycles that often require up to 100 days.
Currently, BUZZEBEES supports over 500 enterprise platforms, more than 1,500 SME and merchant networks, and an aggregate user base exceeding 200 million consumer and distributor accounts. Notable deployments include Tops’ personalized loyalty platform, which serves over 210,000 active users and has processed more than 40 million reward redemptions. In 2025, the company generated over 2 billion baht annually in gross merchandise value (GMV) through international affiliate channels, saved domestic corporations over 600 million baht annually by replacing reliance on foreign enterprise software, posted 2.964 billion baht in total revenue, and created an average of 260 local tech jobs annually.
2. INSPECTRA MMG: Deep-Learning AI for Mammography Analysis Enhancing Breast Cancer Screening Developed by Perceptra Co., Ltd., INSPECTRA MMG captured first prize in the Social category (Large and Medium Enterprise division). The diagnostic-support AI system assists radiologists in interpreting screening mammograms, specifically targeting the diagnostic complexities posed by dense breast tissue—a characteristic prevalent among Asian women that frequently obscures underlying lesions in standard screenings.
Trained on a proprietary dataset of more than 400,000 mammographic images from Thai cohorts, INSPECTRA MMG detects subtle indicators of malignancy to assist clinical decision-making. Deployed in Thai clinical settings for over three years across more than 220,000 processed patient cases, the tool reduces radiologists’ workloads, optimizes diagnostic throughput, and democratizes access to early cancer detection in medically underserved provinces. Validation data submitted by the company demonstrates an impressive Cancer Detection Rate of 97%, validating AI’s efficacy as a clinical decision-support asset while maintaining physician oversight as the ultimate diagnostic authority. Looking ahead, Perceptra plans to expand outreach via mobile mammography screening units for remote communities, implement an annual software-as-a-service (SaaS) subscription model to fund continued R&D, and scale operations into broader Southeast Asian healthcare markets.
3. MyraShell Aroma: Upcycling Marine Shell Waste into Sustainable Luxury Bio-Materials Developed by Manee Mongkol Gems Factory Co., Ltd., “MyraShell Aroma – Sea of Love” won top honors in the Environmental category (Micro & Small Enterprise, and Social Enterprise division). The initiative upcycles discarded green mussel shells sourced from coastal fishing communities into high-value decorative bio-materials under circular economy principles, effectively curbing coastal waste while establishing sustainable secondary income streams for local artisanal fishers.
The innovation isolates nacre (mother-of-pearl) and calcium carbonate fractions from marine shells, formulating them with bio-based binding polymers and precision engineering techniques into durable, aesthetically sophisticated materials suitable for fine jewelry and luxury decor. MyraShell Aroma features a calibrated micro-porous surface that absorbs and disperses fragrances ambiently without electricity, designed for repeated aromatic refills.
The company has expanded its portfolio under the MyraShell and MyraGem brands to supply interior panels, lighting fixtures, and architectural finishes to luxury five-star hospitality brands. Manee Mongkol Gems collaborates with the Chonburi Fisheries Association and the Sawang Pratheep Community Enterprise for ethical raw material sourcing, complete with origin-traceability protocols, and partners with Kasetsart University on material validation with research grant backing from the NIA. The breakthrough gained international acclaim at Milan Design Week at Superstudio Events in Milan, Italy, where the team exhibited a 3×3-meter “Sea of Love” feature wall. Capitalizing on sustainable luxury storytelling, the company is actively expanding its direct export channels across Italy, Germany, France, and Hong Kong.
Supporting Broader Innovation Ecosystems Alongside the flagship honors, the ceremony presented accolades across complementary specialized initiatives:
The 22nd National Innovation Awards: Organized directly by the NIA to honor impact across five dedicated pillars: Economy, Society, Environment, Innovation Communicator, and Innovative Organization. The 2026 edition drew 437 competitive submissions.
The 26th Innovation Thailand Awards: Co-organized with the Science Society of Thailand under the Patronage of His Majesty the King, this initiative fosters youth-led innovation and guides intellectual property toward viable commercialization across two academic tiers: Higher Vocational/Undergraduate and Vocational/Secondary levels (attracting 494 entries).
The 18th Thai Rice Innovation Awards: Co-hosted with the Thai Rice Foundation under Royal Patronage to incentivize high-value product transformation and process innovation across the rice value chain. Awards were conferred across Industrial and Community Enterprise categories, drawing 82 submissions.
Serving as the nation’s “Focal Conductor,” the NIA continues to align with domestic and international partners through its core Groom – Grant – Growth – Global framework. This integrated strategy aims to expand Thailand’s cohort of market-ready innovation-driven enterprises (IDEs), catalyze economic value creation, and fortify national competitiveness to firmly cement Thailand’s standing as an internationally recognized Innovation Nation.
Hashtag: #NIA
The issuer is solely responsible for the content of this announcement.
TOKYO, JAPAN – Media OutReach Newswire – 9 November 2026 – TORRAS (楽創未来株式会社), a mobile accessory brand, has released the USBC charger ‘FlashEye Dot’. FlashEye Dot is a smart charger that detects the iPhone model and battery status to deliver appropriate charging power. It shows the device model name, charging output and remaining battery level on its display in real time. It offers up to 45W USBC output. It can charge an iPhone 17 Pro up to 50% in around 20 minutes and is also compatible with iPad and MacBook Air. Equipped with GaN and ToraIce lowtemperature charging protection technology, it regulates temperature during charging and features over-current, over-voltage and overheating protection. Its 45° angled display auto-rotates based on the charger’s orientation. Tapping the top of the Dot triggers fun facial expressions on screen. The product comes with an 18-month warranty starting from the date of purchase.
Note: iPhone 18 supports fast charging but does not work with the model detection function.
Hashtag: #TORRAS
The issuer is solely responsible for the content of this announcement.
Original ekiben and limited-edition merchandise featuring exclusive new illustrations of characters in “Taisho modern travel outfits” will be available starting December 1! The “Tokaido: Journey of Infinite Excitement” campaign is here to make your Shinkansen trip even more fun.
TOKYO, JAPAN – Media OutReach Newswire – 9 November 2026 – JR Central Retailing Plus Co., Ltd. (Headquarters: Nagoya City, Aichi Prefecture), which operates stores such as “PLUSTA” at major Tokaido Shinkansen stations (including Tokyo, Nagoya, Kyoto, and Shin-Osaka), will host the “Tokaido: Journey of Infinite Excitement” campaign in collaboration with the anime Demon Slayer: Kimetsu no Yaiba for a limited time from Tuesday, December 1, 2026, to Monday, January 11, 2027.
During the campaign, JR-PLUS will offer “ekiben”—an essential part of Japanese railway travel—as well as exclusive merchandise available only during this campaign.
■ Campaign overview
Campaign name: “Tokaido: Journey of Infinite Excitement” campaign
Campaign period: Tuesday, December 1, 2026 – Monday, January 11, 2027
Locations: “PLUSTA,” “Bellmart,” “PRECIOUS DELI & GIFT,” and other stores at Tokaido Shinkansen stations (Tokyo, Shinagawa, Shin-Yokohama, Nagoya, Kyoto, Shin-Osaka, etc.)
■ Campaign highlights Highlight 1: Exclusive to this campaign! “Exclusive new illustrations” Five characters (Tanjiro Kamado, Giyu Tomioka, Shinobu Kocho, Muichiro Tokito, and Mitsuri Kanroji) will be featured in new illustrations wearing outfits exclusive to this campaign.
Highlight 2: For the best memories of your Japan trip! Anime “Demon Slayer” Special Collaboration Ekiben (with Novelty) We have prepared two types of ekiben: one featuring local gourmet specialties along the Tokaido route, and another colorful bento packed with the world of Tanjiro and the Hashira.
1. Available Dec. 1: Onward, Down the Tokaido! Demon Slayer Corps Journey Ekiben
Features: In addition to Tokaido route gourmet specialties like beef-on-rice made with premium beef from the Tokaido or Kansai regions and Fukagawa-meshi, this bento brings the characters to life through gorgeous side dishes, such as the “sunlit simmered egg” reflecting Tanjiro Kamado’s kindness.
Limited Novelty: Plastic clear card with a new illustration (one of 5 designs, included at random)
2. Available Dec. 22: Total Concentration on Flavor! Demon Slayer Corps Colorful Ekiben
Features: This vibrant bento vividly expresses the individuality of the five characters. It includes a Tanjiro Kamado motif that allows customers to complete the dish themselves by placing the seaweed on top, as well as a “sakura mochi” inspired by Mitsuri Kanroji.
Limited Novelty: Metallic postcard with a new illustration (one of 5 designs, included at random)
Highlight 3: Perfect as a trip memento or gift! Limited original merchandise featuring the new illustrations We will sell premium, exclusive merchandise featuring the new illustrations that can only be obtained here. The design of these items is inspired by the characters traveling along the Tokaido route. This carefully crafted lineup, overflowing with the charm of the exclusive new illustrations, is perfect as a memento of your trip to Japan or as a souvenir for dear friends.
Acrylic stands (5 types)
Trading acrylic keychains (6 types)
Trading button badges (10 types, including special holographic versions)
HONG KONG SAR – Media OutReach Newswire – 6 November 2026 – During Hong Kong FinTech Week, UnionPay International announced the signing of a Memorandum of Understanding (MOU) with TenPay Global, Tencent’s cross-border payment platform. This agreement marks the first collaboration between the two parties in the cross-border remittance sector, aiming to jointly deliver convenient and efficient cross-border transfer services.
Under the MOU, the two companies will jointly explore convenient cross-border remittance services, drawing on their respective strengths in networks, platforms and use cases to improve cross-border remittance efficiency and lower last-mile costs.
Beyond this collaboration, UnionPay International continues to drive innovation in international money transfers through its flagship UnionPay MoneyExpress solution. UnionPay MoneyExpress brings mature and comprehensive cross-border capabilities to the partnership, catering to diverse scenarios including personal remittances, corporate payroll, and international insurance claim payouts. For corporate clients, the service streamlines foreign exchange conversions and reduces intermediary bank overhead, enabling businesses to optimize operational efficiency and manage cross-border funds with greater precision.
As cross-border economic activities accelerate across the Asia-Pacific region, the demand for international capital flows continues to rise. UnionPay has already rolled out UnionPay MoneyExpress across 14 APEC economies, establishing a solid foundation for this collaboration.
Moving forward, UnionPay International will continue to deliver secure, efficient, and innovative cross-border payment solutions for global consumers and enterprise partners.
Hashtag: #UnionPay
The issuer is solely responsible for the content of this announcement.
An Asia digital transformation programme for founders and SMEs, starting in Malaysia, with a full refund if the delivery date is missed
KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 9 November 2026 – Fully customised business software and AI solutions, built by engineers and backed by a full refund if the agreed delivery date is missed. Starting in Malaysia and rolling out across Asia, made possible by more than 100 partners.
Nexawork AI Founders
Nexawork AI is an Asia focused technology company building the AI Business Operating System. It was co-founded by Allen Tan Chee Hoe, its Chief Executive Officer, and Sky Wee, its Chief Business Development Officer.
Today Allen Tan Chee Hoe announced the launch of Nexawork AI’s Asia digital transformation programme, which helps founders, project owners and small and medium enterprises (SMEs) build their first digital product. It offers custom software development, including AI solutions and AI agents, starting with a Starter Pack at RM19,900.00, with a full refund of the development fee if Nexawork AI misses the delivery date in the contract.
The programme starts in Malaysia, its first market in Southeast Asia, before extending across Asia. Applications are open now at nexawork.ai. Its pricing is made possible by more than 100 partners, who share the work and bring businesses to the programme.
Why Asia’s SMEs hold back on AI and digital transformation Asia runs on small businesses. Across 26 economies tracked by the Asian Development Bank (ADB), micro, small and medium enterprises make up 99.8% of all enterprises, employ 67.6% of the workforce and produce 38.7% of national output. Yet many still run on paper and spreadsheets, SME digitalisation lags, and AI is widening the gap. In South Korea, a 2024 Korea Federation of SMEs survey of 300 SMEs found only 5.3% using AI, and the obstacle cited most was the lack of AI services built for their needs.
Cost and risk add to the hesitation. In Malaysia, 2026 industry estimates put even a basic first version of mobile software at RM30,000 to RM60,000, and most SME projects at RM60,000 or more. For a first time founder, that is a large bet on one vendor. Owners are avoiding risk, not technology.
“Transformation fails on the first invoice, not on the technology,” said Allen Tan Chee Hoe, Co-Founder and Chief Executive Officer of Nexawork AI. “We are not trying to reprice the market. We want to give many SMEs the confidence to take their first step into digitisation, together with more than 100 partners, so a founder anywhere in Asia can build a first digital product without betting the year on it. And we are not here to replace anyone’s workforce. Our AI brings productivity to business owners and their teams, so that adoption actually happens.”
A full refund if the delivery date is missed If Nexawork AI misses the delivery date in the contract, the business receives a full refund of the development fee. The clock starts when the business provides complete information and access, and the scope is fixed in writing before work begins.
Custom software development and AI solutions built around the business Every system is shaped around the individual business. Professional engineers write, review and test every build, and the owner needs no technical knowledge. Projects can include a native mobile platform for ordering, payment through the business’s own provider, delivery tracking and referrals, an admin console, connections to existing software, and AI built for the business, from AI solutions on its own data to AI agents that answer enquiries or follow up on orders.
RM19,900.00 is the Starter Pack, the entry point to the programme: a focused first system built around one core workflow, such as taking orders or bookings, with an admin console for the owner. Builds with more features, AI, payments or integrations are scoped and priced above the Starter Pack.
Why the programme price is possible: more than 100 partners The programme is designed to grow the market, not to undercut it. The price is not set to compete with the market: most SMEs would not commission development at RM100,000 or more, so the programme reaches businesses that would otherwise not digitise at all, rather than taking work from established developers. The Starter Pack can start at RM19,900.00 because more than 100 partners share the work and bring businesses to the programme, so less of each project’s price goes on sales and marketing.
Nexawork AI’s team shapes each founder’s first product before any code is written. Lavie System Solutions brings almost two decades of development experience, so proven building blocks are not reinvented for every project. Healing Mind Group, led by Lee Hong Rui, a trainer accredited by HRD Corp, Malaysia’s Human Resource Development Corporation, joins as Business Process and SME Transformation Partner to map workflows and prepare teams. Dova Space looks after the people side of change, Eco Bee Biotech and Eco Bee Shop introduce the programme to their network, and Jayv Chang Yoon Voon, marketing partner for Southeast Asia, reaches businesses through partner and community channels.
How the programme works Each custom software development project starts with a written scope, after which the price and the delivery date go into the contract. The build runs in about twelve sprints over about three months. Every project includes three months of free maintenance; hosting, domain and infrastructure are paid by the business to its own providers, from about US$100 a month. Every system is built to connect directly to the Nexawork AI platform, which is expected to launch by the second quarter of 2027.
The founders behind Nexawork AI Allen Tan Chee Hoe is a serial founder and product architect with 15 years of experience in technology and product development. According to internal operating records, he previously built a startup to more than 4 million users and 60,000 business owners, and his teams have supported more than 180 projects globally for companies that together raised more than US$200 million. Sky Wee, who leads global business development and partnerships, is a Singapore based serial entrepreneur and venture investor.
The Nexawork AI Partner App Nexawork AI will also launch the Nexawork AI Partner App, expected in the first quarter of 2027, so referral partners can refer businesses to the platform and handle enquiries and introductions in one place. Partners can register their interest at nexawork.ai.
Larger digital transformation projects Alongside the programme, Nexawork AI is helping established companies digitise through larger projects, each scoped and priced on its own and separate from the RM19,900.00 Starter Pack. They include Vorahome, a home services platform founded by Alan Foong, Vincent Wong and Ivan Hiew Chin Woon; and Big Ben Dining Group, a food, entertainment and technology dining concept founded by Bengemen Tan Boon Yong.
How to apply To claim the programme, a business needs an official Programme Code from the Nexawork AI sales team. Founders, project owners and businesses can apply at nexawork.ai or approach any Nexawork AI Sales Manager across Southeast Asia. A salesperson will contact them to confirm the fit and issue the code, which opens the scoping session; the sales team verifies each business through its code and uses it to track every approved project. The programme is open while it lasts, until Nexawork AI announces its close, and codes, like places, are limited each month. Hashtag: #NexaworkAI #WorkLessWinMore #DigitalTransformation #CustomSoftware #AIforBusiness #AIAgents #SMEMalaysia #SMEDigitalisation #SoftwareDevelopment
The issuer is solely responsible for the content of this announcement.
About Nexawork AI
Nexawork AI is building the AI Business Operating System for solo entrepreneurs, small teams and established businesses in Asia: one platform to run your work and your business. Money and legal commitments always wait for a human. The platform is in beta with design partners and is expected to launch by the second quarter of 2027. Nexawork AI was co-founded by Allen Tan Chee Hoe, its Chief Executive Officer, and Sky Wee, its Chief Business Development Officer. Work Less. Win More. AI Does the Rest. nexawork.ai
About Eco Bee Biotech and Eco Bee Shop
Eco Bee Biotech and Eco Bee Shop is a Malaysian bee biotechnology, conservation and wellness enterprise founded by Cathie Tan in 2002. It develops Kelulut (stingless bee) honey, propolis and other wellness products, and in 2026 was recognised by ASIA Records and ASEAN Records for its alcohol free halal Kelulut propolis extract. Bee conservation is at the heart of its mission, including its planned Eco Bee Nature Exchange, guided by its philosophy: Save Bees, Empowering People, Pure Quality. beeshop.com.my
About Lavie System Solutions
Lavie System Solutions, led by Lai Yu Long, is a Johor based development company founded in 2008 that builds custom software, enterprise and point of sale systems and online stores. lvss.com.my
About Healing Mind Group
Healing Mind Group is a training provider led by Lee Hong Rui, who brings experience in finance and corporate management, a background in process transformation and trainer accreditation with HRD Corp. It helps SMEs map their business workflows, identify operational gaps and prepare their teams to adopt systems that improve productivity.
About Dova Space
Dova Space, led by Debbie Hew Sio Yee and Hew Khai Rin, is a holistic health and wellness centre offering personalised, data driven care. It brings Traditional Chinese Medicine, modern medical expertise, natural healing and advanced medical devices under one roof, with a strong focus on sleep health: sleep care consultations, sleep quality and autonomic nervous system assessments, home use medical devices and long term sleep management programmes. Better Sleep. Better Health. Better Living. dova.space